Table II.
Association of miR-18a, miR-135b, miR-204 and miR-497 expression with clinicopathological factors.
miR-18a | miR-135b | miR-204 | miR-497 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Variable | Total no. of patients | High | Low | P-value | High | Low | P-value | High | Low | P-value | High | Low | P-value |
Sex | |||||||||||||
Male | 11 | 6 | 5 | 0.740 | 6 | 5 | 0.740 | 4 | 7 | 0.319 | 3 | 8 | 0.965 |
Female | 51 | 25 | 26 | 25 | 26 | 27 | 24 | 28 | 23 | ||||
Age, years | |||||||||||||
≥50 | 26 | 14 | 12 | 0.607 | 13 | 13 | 0.797 | 14 | 12 | 0.607 | 15 | 11 | 0.303 |
<50 | 36 | 17 | 19 | 18 | 18 | 17 | 19 | 16 | 20 | ||||
Metastasis status | |||||||||||||
Yes | 17 | 15 | 2 | <0.001 | 14 | 3 | 0.002 | 8 | 9 | 0.776 | 9 | 8 | 0.776 |
No | 45 | 16 | 29 | 17 | 28 | 23 | 22 | 22 | 23 | ||||
Maximum diameter of lymph nodes, mm | |||||||||||||
≥10 | 43 | 25 | 18 | 0.054 | 24 | 19 | 0.168 | 19 | 24 | 0.168 | 22 | 21 | 0.783 |
<10 | 19 | 6 | 13 | 7 | 12 | 12 | 7 | 9 | 10 |
miR, microRNA.